Betadex Sulfobutyl Ether Sodium SBECD for Parenteral Drug Formulations – Xi’an DELI Biochemical

Betadex Sulfobutyl Ether Sodium SBECD (CAS 182410-00-0) is a high-purity, water-soluble cyclodextrin derivative specifically designed for injectable and parenteral pharmaceutical products. This excipient enhances the solubility, stability, and bioavailability of poorly soluble active pharmaceutical ingredients (APIs). Its unique molecular structure forms stable inclusion complexes, ensuring consistent therapeutic performance and reliable drug delivery.

Suitable for intravenous, intramuscular, and subcutaneous formulations, SBECD prevents precipitation, reduces chemical degradation, and maintains the stability of sensitive APIs. It is also ideal for ophthalmic solutions, nasal sprays, and other liquid formulations requiring solubility enhancement and stability. High water solubility, low toxicity, and biocompatibility make it a preferred excipient for research, clinical development, and commercial injectable products.

Xi’an DELI Biochemical Industry Co., Ltd., established in 1999, has over 26 years of experience providing high-quality cyclodextrin derivatives including SBECD and Hydroxypropyl Betadex. We ensure consistent batch-to-batch purity, reliable performance, and technical support for global pharmaceutical, veterinary, and cosmetic markets. Detailed technical data, certificates of analysis (COA), and sample evaluation are available to facilitate formulation development and optimize product performance.

Choose Betadex Sulfobutyl Ether Sodium SBECD for Parenteral Drug Formulations from Xi’an DELI Biochemical to enhance the stability, solubility, and performance of your injectable drug products. Contact our team today for inquiries, quotations, or sample requests.

Keywords: Betadex Sulfobutyl Ether Sodium, SBECD, parenteral drug formulations, injectable excipient, solubility enhancer, Xi’an DELI Biochemical